Assessment of New Molecular Entities Approved for Cancer Treatment in 2020

This cross-sectional study of all hematology/oncology drugs approved by the US Food and Drug Administration in 2020 assesses the functioning of the drug approval process following disruptions related to the COVID-19 pandemic.

Detalles Bibliográficos
Autores principales: Smith, Claire E. P., Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164099/
https://www.ncbi.nlm.nih.gov/pubmed/34047795
http://dx.doi.org/10.1001/jamanetworkopen.2021.12558
_version_ 1783701043967688704
author Smith, Claire E. P.
Prasad, Vinay
author_facet Smith, Claire E. P.
Prasad, Vinay
author_sort Smith, Claire E. P.
collection PubMed
description This cross-sectional study of all hematology/oncology drugs approved by the US Food and Drug Administration in 2020 assesses the functioning of the drug approval process following disruptions related to the COVID-19 pandemic.
format Online
Article
Text
id pubmed-8164099
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-81640992021-06-17 Assessment of New Molecular Entities Approved for Cancer Treatment in 2020 Smith, Claire E. P. Prasad, Vinay JAMA Netw Open Research Letter This cross-sectional study of all hematology/oncology drugs approved by the US Food and Drug Administration in 2020 assesses the functioning of the drug approval process following disruptions related to the COVID-19 pandemic. American Medical Association 2021-05-28 /pmc/articles/PMC8164099/ /pubmed/34047795 http://dx.doi.org/10.1001/jamanetworkopen.2021.12558 Text en Copyright 2021 Smith CEP et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Smith, Claire E. P.
Prasad, Vinay
Assessment of New Molecular Entities Approved for Cancer Treatment in 2020
title Assessment of New Molecular Entities Approved for Cancer Treatment in 2020
title_full Assessment of New Molecular Entities Approved for Cancer Treatment in 2020
title_fullStr Assessment of New Molecular Entities Approved for Cancer Treatment in 2020
title_full_unstemmed Assessment of New Molecular Entities Approved for Cancer Treatment in 2020
title_short Assessment of New Molecular Entities Approved for Cancer Treatment in 2020
title_sort assessment of new molecular entities approved for cancer treatment in 2020
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164099/
https://www.ncbi.nlm.nih.gov/pubmed/34047795
http://dx.doi.org/10.1001/jamanetworkopen.2021.12558
work_keys_str_mv AT smithclaireep assessmentofnewmolecularentitiesapprovedforcancertreatmentin2020
AT prasadvinay assessmentofnewmolecularentitiesapprovedforcancertreatmentin2020

Ejemplares similares